Neuren Pharmaceuticals relies on Daybue for Rett syndrome. Here is what the market weighs as healthcare shares lead.
Can ASX 200's Neuren (ASX:NEU) Keep the Daybue Momentum Rolling? - Kalkine Media
Neuren Pharmaceuticals relies on Daybue for Rett syndrome. Here is what the market weighs as healthcare shares lead.